Pharmacy group Dis-Chem says its recent string of acquisitions helped its revenue exceed R30bn for the first time in its history in its 2022 financial year, and it is optimistic about both a normalisation of shopping habits and better-than-expected uptake of its new health insurance offerings.

Dis-Chem’s health and personal care focus means it remains in the resilient part of the consumer retail market, CFO Rui Morais told Business Day, and the group is encouraged by returning footfall at larger malls, which consumers had avoided during the pandemic...